These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 3961958)
41. [Chronic painters' disease. A follow-up study of 26 house painters occupational and economical situations]. Damgaard M; Arlien-Søborg P; Bruhn P; Christensen EL Ugeskr Laeger; 1981 Nov; 143(46):3075-80. PubMed ID: 7331006 [No Abstract] [Full Text] [Related]
42. [What do we know about occupational cancer?]. Lynge E; Olsen JH; Jensen OM Ugeskr Laeger; 1983 Nov; 145(46):3583-6. PubMed ID: 6649147 [No Abstract] [Full Text] [Related]
43. Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. Andrès E; Noel E Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):241-2. PubMed ID: 15262367 [No Abstract] [Full Text] [Related]
44. [Occupational exposure to chemical carcinogens in Poland, 2001]. Konieczko K; Czerczak S; Kluszczyński D Med Pr; 2004; 55(1):3-6. PubMed ID: 15156760 [TBL] [Abstract][Full Text] [Related]
45. Birth defects among children of nurse-anesthetists. Corbett TH; Cornell RG; Endres JL; Lieding K Anesthesiology; 1974 Oct; 41(4):341-4. PubMed ID: 4412215 [No Abstract] [Full Text] [Related]
46. Influence of ethinyl estradiol on C1s inhibitor: a new etiopathogenetic mechanism of angioedema. Case report. Bettoni L Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):49. PubMed ID: 15859360 [No Abstract] [Full Text] [Related]
47. [On the problem of a cancerogenic effect of orally administered estrogen-gestagenic-hormonal combinations. A clinical contribution]. Froewis J; Kremer H Wien Klin Wochenschr; 1965 Oct; 77(42):792-8. PubMed ID: 5880480 [No Abstract] [Full Text] [Related]
48. [Study of hepatic function during hormonal anti-ovulatory treatment]. Bayot D Bull Soc R Belge Gynecol Obstet; 1966; 36(6):507-16. PubMed ID: 5990177 [No Abstract] [Full Text] [Related]
49. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. Christie T J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701 [No Abstract] [Full Text] [Related]
50. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol). Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970 [No Abstract] [Full Text] [Related]
51. [Prevention of carcinogenicity risks in work environment]. Terracini B Med Lav; 1998; 89(2):98-101. PubMed ID: 9673098 [TBL] [Abstract][Full Text] [Related]
53. [Clinical and therapeutic study of a combination of ethinyl nortestosterone acetate and ethinyl estradiol]. Magnier P Gynecol Prat; 1968; 19(1):21-43. PubMed ID: 5748205 [No Abstract] [Full Text] [Related]
54. [Thrombophlebitis in the course of the use of oral contraceptives]. Wolf A; Uremović V Lijec Vjesn; 1969 Jul; 91(7):753-6. PubMed ID: 5199525 [No Abstract] [Full Text] [Related]
55. [Mycoses and oral contraception of the biphasic type]. Eimer H Brux Med; 1974 Sep; 54(9):511-4. PubMed ID: 4410194 [TBL] [Abstract][Full Text] [Related]
56. [Mineral wool production and cancer. The results of an epidemiological study in 1937-1977]. Olsen JH; Jensen OM Ugeskr Laeger; 1983 Sep; 145(38):2951-6. PubMed ID: 6649106 [No Abstract] [Full Text] [Related]
57. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive. Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229 [No Abstract] [Full Text] [Related]
58. [Antiandrogens in female androgenetic alopecia]. Winkler K Hautarzt; 1972 Nov; 23(11):518-9. PubMed ID: 4647431 [No Abstract] [Full Text] [Related]